NewEdge Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
NewEdge Advisors's BCAT Position: Q2 2026 in Review
NewEdge Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 12% in Q2 2026, buying an estimated $33.7K and bringing the position to 19,830 shares worth $316K. The position accounts for ﹤0.01% of the portfolio, ranked #2453.
NewEdge Advisors first reported a position in BCAT in Q2 2025 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.
- NewEdge Advisors held 19,830 shares of BlackRock Capital Allocation Term Trust worth $316K as of Q2 2026.
- NewEdge Advisors bought 2,192 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $33.7K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #2453 holding.
- NewEdge Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2025 and has held it in 5 quarters since.
- 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.
Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.